Metabolomics Market Size, Share & Industry Analysis, By Offering (Products {Instruments and Consumables}, Software, and Services), By Technique (Liquid Chromatography-Mass Spectrometry (LC-MS), Gas Chromatography-Mass Spectrometry (GC-MS), Nuclear Magnetic Resonance Spectroscopy (NMR), and Others), By Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, & Others), By Disease Indication (Cancer, Cardiovascular Diseases, Neurological Disorders, & Others), By End User (Pharmaceutical and Biotechnology Companies, CROs / CMOs, & Others), and Regional Forecast, 2026-2034

Last Updated: March 03, 2026 | Format: PDF | Report ID: FBI115625

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Diseases, By Key Regions
2. Overview: Technological Advancements in Metabolomics
3. Regulatory Scenario, By Key Countries/Regions
4. New Product Launches, By Key Players
5. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, and Others)
Global Metabolomics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Offering
  1. Products
    1. Instruments
    2. Consumables
  2. Software
  3. Services
2. Market Analysis, Insights and Forecast – By Technique
  1. Liquid Chromatography-Mass Spectrometry (LC-MS)
  2. Gas Chromatography-Mass Spectrometry (GC-MS)
  3. Nuclear Magnetic Resonance Spectroscopy (NMR)
  4. Others
3. Market Analysis, Insights and Forecast – By Application
  1. Biomarker Discovery
  2. Drug Discovery
  3. Toxicology Testing
  4. Precision Medicine
  5. Others
4. Market Analysis, Insights and Forecast – By Disease Indication
  1. Cancer
  2. Cardiovascular Diseases
  3. Neurological Disorder
  4. Metabolic Disorder
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. CROs / CMOs
  3. Academic & Research Institutes
  4. Diagnostic Labs
  5. Others
6. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Metabolomics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Offering
  1. Products
    1. Instruments
    2. Consumables
  2. Software
  3. Services
2. Market Analysis, Insights and Forecast – By Technique
  1. Liquid Chromatography-Mass Spectrometry (LC-MS)
  2. Gas Chromatography-Mass Spectrometry (GC-MS)
  3. Nuclear Magnetic Resonance Spectroscopy (NMR)
  4. Others
3. Market Analysis, Insights and Forecast – By Application
  1. Biomarker Discovery
  2. Drug Discovery
  3. Toxicology Testing
  4. Precision Medicine
  5. Others
4. Market Analysis, Insights and Forecast – By Disease Indication
  1. Cancer
  2. Cardiovascular Diseases
  3. Neurological Disorder
  4. Metabolic Disorder
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. CROs / CMOs
  3. Academic & Research Institutes
  4. Diagnostic Labs
  5. Others
6. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Metabolomics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Offering
  1. Products
    1. Instruments
    2. Consumables
  2. Software
  3. Services
2. Market Analysis, Insights and Forecast – By Technique
  1. Liquid Chromatography-Mass Spectrometry (LC-MS)
  2. Gas Chromatography-Mass Spectrometry (GC-MS)
  3. Nuclear Magnetic Resonance Spectroscopy (NMR)
  4. Others
3. Market Analysis, Insights and Forecast – By Application
  1. Biomarker Discovery
  2. Drug Discovery
  3. Toxicology Testing
  4. Precision Medicine
  5. Others
4. Market Analysis, Insights and Forecast – By Disease Indication
  1. Cancer
  2. Cardiovascular Diseases
  3. Neurological Disorder
  4. Metabolic Disorder
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. CROs / CMOs
  3. Academic & Research Institutes
  4. Diagnostic Labs
  5. Others
6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Metabolomics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Offering
  1. Products
    1. Instruments
    2. Consumables
  2. Software
  3. Services
2. Market Analysis, Insights and Forecast – By Technique
  1. Liquid Chromatography-Mass Spectrometry (LC-MS)
  2. Gas Chromatography-Mass Spectrometry (GC-MS)
  3. Nuclear Magnetic Resonance Spectroscopy (NMR)
  4. Others
3. Market Analysis, Insights and Forecast – By Application
  1. Biomarker Discovery
  2. Drug Discovery
  3. Toxicology Testing
  4. Precision Medicine
  5. Others
4. Market Analysis, Insights and Forecast – By Disease Indication
  1. Cancer
  2. Cardiovascular Diseases
  3. Neurological Disorder
  4. Metabolic Disorder
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. CROs / CMOs
  3. Academic & Research Institutes
  4. Diagnostic Labs
  5. Others
6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Southeast Asia
  5. Australia
  6. Rest of Asia Pacific
Latin America Metabolomics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Offering
  1. Products
    1. Instruments
    2. Consumables
  2. Software
  3. Services
2. Market Analysis, Insights and Forecast – By Technique
  1. Liquid Chromatography-Mass Spectrometry (LC-MS)
  2. Gas Chromatography-Mass Spectrometry (GC-MS)
  3. Nuclear Magnetic Resonance Spectroscopy (NMR)
  4. Others
3. Market Analysis, Insights and Forecast – By Application
  1. Biomarker Discovery
  2. Drug Discovery
  3. Toxicology Testing
  4. Precision Medicine
  5. Others
4. Market Analysis, Insights and Forecast – By Disease Indication
  1. Cancer
  2. Cardiovascular Diseases
  3. Neurological Disorder
  4. Metabolic Disorder
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. CROs / CMOs
  3. Academic & Research Institutes
  4. Diagnostic Labs
  5. Others
6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Metabolomics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Offering
  1. Products
    1. Instruments
    2. Consumables
  2. Software
  3. Services
2. Market Analysis, Insights and Forecast – By Technique
  1. Liquid Chromatography-Mass Spectrometry (LC-MS)
  2. Gas Chromatography-Mass Spectrometry (GC-MS)
  3. Nuclear Magnetic Resonance Spectroscopy (NMR)
  4. Others
3. Market Analysis, Insights and Forecast – By Application
  1. Biomarker Discovery
  2. Drug Discovery
  3. Toxicology Testing
  4. Precision Medicine
  5. Others
4. Market Analysis, Insights and Forecast – By Disease Indication
  1. Cancer
  2. Cardiovascular Diseases
  3. Neurological Disorder
  4. Metabolic Disorder
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. CROs / CMOs
  3. Academic & Research Institutes
  4. Diagnostic Labs
  5. Others
6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of the Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
  1. Merck KGaA
  2. Thermo Fisher Scientific Inc.
  3. DH Life Sciences, LLC.
  4. Agilent Technologies, Inc.
  5. Bruker Corporation
  6. Waters Corporation
  7. Shimadzu Corporation
  8. Trinity Biotech
  9. Bio-Rad Laboratories, Inc.

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Diseases, By Key Regions
2. Overview: Technological Advancements in Metabolomics
3. Regulatory Scenario, By Key Countries/Regions
4. New Product Launches, By Key Players
5. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, and Others)
Global Metabolomics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Offering
  1. Products
    1. Instruments
    2. Consumables
  2. Software
  3. Services
2. Market Analysis, Insights and Forecast – By Technique
  1. Liquid Chromatography-Mass Spectrometry (LC-MS)
  2. Gas Chromatography-Mass Spectrometry (GC-MS)
  3. Nuclear Magnetic Resonance Spectroscopy (NMR)
  4. Others
3. Market Analysis, Insights and Forecast – By Application
  1. Biomarker Discovery
  2. Drug Discovery
  3. Toxicology Testing
  4. Precision Medicine
  5. Others
4. Market Analysis, Insights and Forecast – By Disease Indication
  1. Cancer
  2. Cardiovascular Diseases
  3. Neurological Disorder
  4. Metabolic Disorder
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. CROs / CMOs
  3. Academic & Research Institutes
  4. Diagnostic Labs
  5. Others
6. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Metabolomics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Offering
  1. Products
    1. Instruments
    2. Consumables
  2. Software
  3. Services
2. Market Analysis, Insights and Forecast – By Technique
  1. Liquid Chromatography-Mass Spectrometry (LC-MS)
  2. Gas Chromatography-Mass Spectrometry (GC-MS)
  3. Nuclear Magnetic Resonance Spectroscopy (NMR)
  4. Others
3. Market Analysis, Insights and Forecast – By Application
  1. Biomarker Discovery
  2. Drug Discovery
  3. Toxicology Testing
  4. Precision Medicine
  5. Others
4. Market Analysis, Insights and Forecast – By Disease Indication
  1. Cancer
  2. Cardiovascular Diseases
  3. Neurological Disorder
  4. Metabolic Disorder
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. CROs / CMOs
  3. Academic & Research Institutes
  4. Diagnostic Labs
  5. Others
6. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Metabolomics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Offering
  1. Products
    1. Instruments
    2. Consumables
  2. Software
  3. Services
2. Market Analysis, Insights and Forecast – By Technique
  1. Liquid Chromatography-Mass Spectrometry (LC-MS)
  2. Gas Chromatography-Mass Spectrometry (GC-MS)
  3. Nuclear Magnetic Resonance Spectroscopy (NMR)
  4. Others
3. Market Analysis, Insights and Forecast – By Application
  1. Biomarker Discovery
  2. Drug Discovery
  3. Toxicology Testing
  4. Precision Medicine
  5. Others
4. Market Analysis, Insights and Forecast – By Disease Indication
  1. Cancer
  2. Cardiovascular Diseases
  3. Neurological Disorder
  4. Metabolic Disorder
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. CROs / CMOs
  3. Academic & Research Institutes
  4. Diagnostic Labs
  5. Others
6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Metabolomics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Offering
  1. Products
    1. Instruments
    2. Consumables
  2. Software
  3. Services
2. Market Analysis, Insights and Forecast – By Technique
  1. Liquid Chromatography-Mass Spectrometry (LC-MS)
  2. Gas Chromatography-Mass Spectrometry (GC-MS)
  3. Nuclear Magnetic Resonance Spectroscopy (NMR)
  4. Others
3. Market Analysis, Insights and Forecast – By Application
  1. Biomarker Discovery
  2. Drug Discovery
  3. Toxicology Testing
  4. Precision Medicine
  5. Others
4. Market Analysis, Insights and Forecast – By Disease Indication
  1. Cancer
  2. Cardiovascular Diseases
  3. Neurological Disorder
  4. Metabolic Disorder
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. CROs / CMOs
  3. Academic & Research Institutes
  4. Diagnostic Labs
  5. Others
6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Southeast Asia
  5. Australia
  6. Rest of Asia Pacific
Latin America Metabolomics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Offering
  1. Products
    1. Instruments
    2. Consumables
  2. Software
  3. Services
2. Market Analysis, Insights and Forecast – By Technique
  1. Liquid Chromatography-Mass Spectrometry (LC-MS)
  2. Gas Chromatography-Mass Spectrometry (GC-MS)
  3. Nuclear Magnetic Resonance Spectroscopy (NMR)
  4. Others
3. Market Analysis, Insights and Forecast – By Application
  1. Biomarker Discovery
  2. Drug Discovery
  3. Toxicology Testing
  4. Precision Medicine
  5. Others
4. Market Analysis, Insights and Forecast – By Disease Indication
  1. Cancer
  2. Cardiovascular Diseases
  3. Neurological Disorder
  4. Metabolic Disorder
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. CROs / CMOs
  3. Academic & Research Institutes
  4. Diagnostic Labs
  5. Others
6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Metabolomics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Offering
  1. Products
    1. Instruments
    2. Consumables
  2. Software
  3. Services
2. Market Analysis, Insights and Forecast – By Technique
  1. Liquid Chromatography-Mass Spectrometry (LC-MS)
  2. Gas Chromatography-Mass Spectrometry (GC-MS)
  3. Nuclear Magnetic Resonance Spectroscopy (NMR)
  4. Others
3. Market Analysis, Insights and Forecast – By Application
  1. Biomarker Discovery
  2. Drug Discovery
  3. Toxicology Testing
  4. Precision Medicine
  5. Others
4. Market Analysis, Insights and Forecast – By Disease Indication
  1. Cancer
  2. Cardiovascular Diseases
  3. Neurological Disorder
  4. Metabolic Disorder
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Pharmaceutical and Biotechnology Companies
  2. CROs / CMOs
  3. Academic & Research Institutes
  4. Diagnostic Labs
  5. Others
6. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of the Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
  1. Merck KGaA
  2. Thermo Fisher Scientific Inc.
  3. DH Life Sciences, LLC.
  4. Agilent Technologies, Inc.
  5. Bruker Corporation
  6. Waters Corporation
  7. Shimadzu Corporation
  8. Trinity Biotech
  9. Bio-Rad Laboratories, Inc.

Read Less

List of Figures

Figure 1: Global Metabolomics Market Revenue Breakdown (USD Billion, %) by Region, 2025 & 2034

Figure 2: Global Metabolomics Market Value Share (%), by Offering, 2025 & 2034

Figure 3: Global Metabolomics Market Value Share (%), by Technique, 2025 & 2034

Figure 4: Global Metabolomics Market Value Share (%), by Application, 2025 & 2034

Figure 5: Global Metabolomics Market Value Share (%), by Disease Indication, 2025 & 2034

Figure 6: Global Metabolomics Market Value Share (%), by End User, 2025 & 2034

Figure 7: Global Metabolomics Market Value Share (%), by Region, 2025 & 2034

Figure 8: North America Metabolomics Market Value (USD Billion), by Offering, 2025 & 2034

Figure 9: North America Metabolomics Market Value Share (%), by Offering, 2025

Figure 10: North America Metabolomics Market Value (USD Billion), by Technique, 2025 & 2034

Figure 11: North America Metabolomics Market Value Share (%), by Technique, 2025

Figure 12: North America Metabolomics Market Value (USD Billion), by Application, 2025 & 2034

Figure 13: North America Metabolomics Market Value Share (%), by Application, 2025

Figure 14: North America Metabolomics Market Value (USD Billion), by Disease Indication, 2025 & 2034

Figure 15: North America Metabolomics Market Value Share (%), by Disease Indication, 2025

Figure 16: North America Metabolomics Market Value (USD Billion), by End User, 2025 & 2034

Figure 17: North America Metabolomics Market Value Share (%), by End User, 2025

Figure 18: North America Metabolomics Market Value (USD Billion), by Country, 2025 & 2034

Figure 19: North America Metabolomics Market Value Share (%), by Country, 2025

Figure 20: Europe Metabolomics Market Value (USD Billion), by Offering, 2025 & 2034

Figure 21: Europe Metabolomics Market Value Share (%), by Offering, 2025

Figure 22: Europe Metabolomics Market Value (USD Billion), by Technique, 2025 & 2034

Figure 23: Europe Metabolomics Market Value Share (%), by Technique, 2025

Figure 24: Europe Metabolomics Market Value (USD Billion), by Application, 2025 & 2034

Figure 25: Europe Metabolomics Market Value Share (%), by Application, 2025

Figure 26: Europe Metabolomics Market Value (USD Billion), by Disease Indication, 2025 & 2034

Figure 27: Europe Metabolomics Market Value Share (%), by Disease Indication, 2025

Figure 28: Europe Metabolomics Market Value (USD Billion), by End User, 2025 & 2034

Figure 29: Europe Metabolomics Market Value Share (%), by End User, 2025

Figure 30: Europe Metabolomics Market Value (USD Billion), by Country/ Sub-region, 2025 & 2034

Figure 31: Europe Metabolomics Market Value Share (%), by Country/ Sub-region, 2025

Figure 32: Asia Pacific Metabolomics Market Value (USD Billion), by Offering, 2025 & 2034

Figure 33: Asia Pacific Metabolomics Market Value Share (%), by Offering, 2025

Figure 34: Asia Pacific Metabolomics Market Value (USD Billion), by Technique, 2025 & 2034

Figure 35: Asia Pacific Metabolomics Market Value Share (%), by Technique, 2025

Figure 36: Asia Pacific Metabolomics Market Value (USD Billion), by Application, 2025 & 2034

Figure 37: Asia Pacific Metabolomics Market Value Share (%), by Application, 2025

Figure 38: Asia Pacific Metabolomics Market Value (USD Billion), by Disease Indication, 2025 & 2034

Figure 39: Asia Pacific Metabolomics Market Value Share (%), by Disease Indication, 2025

Figure 40: Asia Pacific Metabolomics Market Value (USD Billion), by End User, 2025 & 2034

Figure 41: Asia Pacific Metabolomics Market Value Share (%), by End User, 2025

Figure 42: Asia Pacific Metabolomics Market Value (USD Billion), by Country/ Sub-region, 2025 & 2034

Figure 43: Asia Pacific Metabolomics Market Value Share (%), by Country/ Sub-region, 2025

Figure 44: Latin America Metabolomics Market Value (USD Billion), by Offering, 2025 & 2034

Figure 45: Latin America Metabolomics Market Value Share (%), by Offering, 2025

Figure 46: Latin America Metabolomics Market Value (USD Billion), by Technique, 2025 & 2034

Figure 47: Latin America Metabolomics Market Value Share (%), by Technique, 2025

Figure 48: Latin America Metabolomics Market Value (USD Billion), by Application, 2025 & 2034

Figure 49: Latin America Metabolomics Market Value Share (%), by Application, 2025

Figure 50: Latin America Metabolomics Market Value (USD Billion), by Disease Indication, 2025 & 2034

Figure 51: Latin America Metabolomics Market Value Share (%), by Disease Indication, 2025

Figure 52: Latin America Metabolomics Market Value (USD Billion), by End User, 2025 & 2034

Figure 53: Latin America Metabolomics Market Value Share (%), by End User, 2025

Figure 54: Latin America Metabolomics Market Value (USD Billion), by Country/ Sub-region, 2025 & 2034

Figure 55: Latin America Metabolomics Market Value Share (%), by Country/ Sub-region, 2025

Figure 56: Middle East & Africa Metabolomics Market Value (USD Billion), by Offering, 2025 & 2034

Figure 57: Middle East & Africa Metabolomics Market Value Share (%), by Offering, 2025

Figure 58: Middle East & Africa Metabolomics Market Value (USD Billion), by Technique, 2025 & 2034

Figure 59: Middle East & Africa Metabolomics Market Value Share (%), by Technique, 2025

Figure 60: Middle East & Africa Metabolomics Market Value (USD Billion), by Application, 2025 & 2034

Figure 61: Middle East & Africa Metabolomics Market Value Share (%), by Application, 2025

Figure 62: Middle East & Africa Metabolomics Market Value (USD Billion), by Disease Indication, 2025 & 2034

Figure 63: Middle East & Africa Metabolomics Market Value Share (%), by Disease Indication, 2025

Figure 64: Middle East & Africa Metabolomics Market Value (USD Billion), by End User, 2025 & 2034

Figure 65: Middle East & Africa Metabolomics Market Value Share (%), by End User, 2025

Figure 66: Middle East & Africa Metabolomics Market Value (USD Billion), by Country/ Sub-region, 2025 & 2034

Figure 67: Middle East & Africa Metabolomics Market Value Share (%), by Country/ Sub-region, 2025

Figure 68: Global Metabolomics Market Share (%), by Company, 2025

List of Tables

Table 1: Global Metabolomics Market Revenue (USD Billion) Forecast, by Offering, 2021–2034

Table 2: Global Metabolomics Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 3: Global Metabolomics Market Revenue (USD Billion) Forecast, by Technique, 2021–2034

Table 4: Global Metabolomics Market Revenue (USD Billion) Forecast, by Application, 2021–2034

Table 5: Global Metabolomics Market Revenue (USD Billion) Forecast, by Disease Indication, 2021–2034

Table 6: Global Metabolomics Market Revenue (USD Billion) Forecast, by End User, 2021–2034

Table 7: Global Metabolomics Market Revenue (USD Billion) Forecast, by Region, 2021-2034

Table 8: North America Metabolomics Market Revenue (USD Billion) Forecast, by Offering, 2021–2034

Table 9: North America Metabolomics Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 10: North America Metabolomics Market Revenue (USD Billion) Forecast, by Technique, 2021–2034

Table 11: North America Metabolomics Market Revenue (USD Billion) Forecast, by Application, 2021–2034

Table 12: North America Metabolomics Market Revenue (USD Billion) Forecast, by Disease Indication, 2021–2034

Table 13: North America Metabolomics Market Revenue (USD Billion) Forecast, by End User, 2021–2034

Table 14: North America Metabolomics Market Revenue (USD Billion) Forecast, by Country, 2021-2034

Table 15: Europe Metabolomics Market Revenue (USD Billion) Forecast, by Offering, 2021–2034

Table 16: Europe Metabolomics Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 17: Europe Metabolomics Market Revenue (USD Billion) Forecast, by Technique, 2021–2034

Table 18: Europe Metabolomics Market Revenue (USD Billion) Forecast, by Application, 2021–2034

Table 19: Europe Metabolomics Market Revenue (USD Billion) Forecast, by Disease Indication, 2021–2034

Table 20: Europe Metabolomics Market Revenue (USD Billion) Forecast, by End User, 2021–2034

Table 21: Europe Metabolomics Market Revenue (USD Billion) Forecast, by Country/ Sub-region, 2021-2034

Table 22: Asia Pacific Metabolomics Market Revenue (USD Billion) Forecast, by Offering, 2021–2034

Table 23: Asia Pacific Metabolomics Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 24: Asia Pacific Metabolomics Market Revenue (USD Billion) Forecast, by Technique, 2021–2034

Table 25: Asia Pacific Metabolomics Market Revenue (USD Billion) Forecast, by Application, 2021–2034

Table 26: Asia Pacific Metabolomics Market Revenue (USD Billion) Forecast, by Disease Indication, 2021–2034

Table 27: Asia Pacific Metabolomics Market Revenue (USD Billion) Forecast, by End User, 2021–2034

Table 28: Asia Pacific Metabolomics Market Revenue (USD Billion) Forecast, by Country/ Sub-region, 2021-2034

Table 29: Latin America Metabolomics Market Revenue (USD Billion) Forecast, by Offering, 2021–2034

Table 30: Latin America Metabolomics Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 31: Latin America Metabolomics Market Revenue (USD Billion) Forecast, by Technique, 2021–2034

Table 32: Latin America Metabolomics Market Revenue (USD Billion) Forecast, by Application, 2021–2034

Table 33: Latin America Metabolomics Market Revenue (USD Billion) Forecast, by Disease Indication, 2021–2034

Table 34: Latin America Metabolomics Market Revenue (USD Billion) Forecast, by End User, 2021–2034

Table 35: Latin America Metabolomics Market Revenue (USD Billion) Forecast, by Country/ Sub-region, 2021-2034

Table 36: Middle East & Africa Metabolomics Market Revenue (USD Billion) Forecast, by Offering, 2021–2034

Table 37: Middle East & Africa Metabolomics Market Revenue (USD Billion) Forecast, by Product, 2021–2034

Table 38: Middle East & Africa Metabolomics Market Revenue (USD Billion) Forecast, by Technique, 2021–2034

Table 39: Middle East & Africa Metabolomics Market Revenue (USD Billion) Forecast, by Application, 2021–2034

Table 40: Middle East & Africa Metabolomics Market Revenue (USD Billion) Forecast, by Disease Indication, 2021–2034

Table 41: Middle East & Africa Metabolomics Market Revenue (USD Billion) Forecast, by End User, 2021–2034

Table 42: Middle East & Africa Metabolomics Market Revenue (USD Billion) Forecast, by Country/ Sub-region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 190

Buy Now

Download Free Sample

Security Code

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services

Clients

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

(APAC) +91 744 740 1245
sales@fortunebusinessinsights.com